Patents by Inventor James L. Kinsella

James L. Kinsella has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140135386
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefore. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Application
    Filed: May 29, 2013
    Publication date: May 15, 2014
    Applicant: The Government of the United States as Represented by the Secretary, Dept. of Health & Human Service
    Inventors: James L. Kinsella, Steven J. Sollott
  • Publication number: 20120088821
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefore. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Application
    Filed: December 15, 2011
    Publication date: April 12, 2012
    Inventors: James L. Kinsella, Steven J. Sollott
  • Publication number: 20110190387
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefore. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Application
    Filed: April 13, 2011
    Publication date: August 4, 2011
    Inventors: James L. Kinsella, Steven J. Sollott
  • Publication number: 20100137418
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefore. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Application
    Filed: November 13, 2009
    Publication date: June 3, 2010
    Inventors: James L. Kinsella, Steven J. Sollott
  • Publication number: 20080194671
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefore. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Application
    Filed: February 21, 2008
    Publication date: August 14, 2008
    Inventors: James L. Kinsella, Steven J. Sollott
  • Publication number: 20030100600
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Application
    Filed: October 15, 2002
    Publication date: May 29, 2003
    Applicant: The Gov't of the U.S.A. as Represented by the Secretary of the Dept. of Health and Human Service
    Inventors: James L. Kinsella, Steven J. Sollott
  • Patent number: 6500859
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Grant
    Filed: April 11, 2002
    Date of Patent: December 31, 2002
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: James L. Kinsella, Steven J. Sollott
  • Publication number: 20020143048
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Application
    Filed: April 11, 2002
    Publication date: October 3, 2002
    Applicant: The Department of Health and Human Services
    Inventors: James L. Kinsella, Steven J. Sollott
  • Patent number: 6429232
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Grant
    Filed: March 21, 1997
    Date of Patent: August 6, 2002
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: James L. Kinsella, Steven J. Sollot
  • Patent number: 6403635
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Grant
    Filed: August 17, 2000
    Date of Patent: June 11, 2002
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: James L. Kinsella, Steven J. Sollot
  • Patent number: 5616608
    Abstract: The present invention is a method of preventing or reducing atherosclerosis or restenosis, and a pharmaceutical preparation used therefor. In particular, it is a method of preventing or reducing atherosclerosis or restenosis after arterial injury by treatment with a low dose of a microtubule stabilizing agent such as taxol or a water soluble taxol derivative. The low dose used in the present invention prevents artery blockage while minimizing any negative side effects associated with the drug.
    Type: Grant
    Filed: April 18, 1996
    Date of Patent: April 1, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: James L. Kinsella, Steven J. Sollott